New from old: Nocodazole displays high affinity for a set of cancer-related kinases, including ABL, c-KIT, BRAF, and MEK. These experimental and computational findings may provide insight into the design of new and potent inhibitors of common kinases based on the nocodazole scaffold.
No takes yet. Share an insight, caveat, or question.
Park et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: